Apoptotic death of cardiac myocytes is associated with ischemic heart disease and chemotherapy-induced cardiomyopathy. Chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) is highly expressed in the heart. However, its specific role in ischemic cardiomyopathy is not fully understood. Here, we demonstrated that CRTH2 disruption markedly improved cardiac recovery in mice postmyocardial infarction and doxorubicin challenge by suppressing cardiomyocyte apoptosis. Mechanistically, CRTH2 activation specifically facilitated endoplasmic reticulum (ER) stress-induced cardiomyocyte apoptosis via caspase-12-dependent pathway. Blockage of m-calpain prevented CRTH2-mediated cardiomyocyte apoptosis under ER stress by suppressing caspase-12 activity. CRTH2 was coupled with G aq to elicit intracellular Ca 2+ flux and activated m-calpain/caspase-12 cascade in cardiomyocytes. Knockdown of caspase-4, an alternative to caspase-12 in humans, markedly alleviated CRHT2 activation-induced apoptosis in human cardiomyocyte response to anoxia. Our findings revealed an unexpected role of CRTH2 in promoting ER stress-induced cardiomyocyte apoptosis, suggesting that CRTH2 inhibition has therapeutic potential for ischemic cardiomyopathy.
Introduction
Cardiovascular diseases continue to be the leading cause of morbidity and mortality worldwide (Benjamin et al, 2017) . Heart failure, characterized by the inability of the ventricle to sufficiently pump blood, is the end stage of various forms of cardiovascular diseases, such as myocardial infarction (MI), valvular heart disease, and cardiomyopathy (Harjola et al, 2016) . Progressive cardiomyocyte loss is a key pathogenic factor in the development of heart failure. Based on morphological manifestations, three distinct types of cell death, namely apoptosis, necrosis, and possibly autophagy, occur in cardiac myocytes during MI and heart failure (Lee & Gustafsson, 2009; Whelan et al, 2010) . While signal transduction pathways involved in cell death have been widely investigated, how cardiac myocytes initiate specific death signaling in response to different stresses, such as ischemia and toxic chemicals, remains unclear.
Apoptosis is a process of programmed cell death that plays an important role in the progression of heart failure (Lee & Gustafsson, 2009) . Two classic pathways-the extrinsic and intrinsic pathwaysmediate apoptotic signaling in mammalian cells (Moe & Marin-Garcia, 2016) . The extrinsic apoptosis is triggered by death ligands, such as Fas and tumor necrosis factor-a. The binding of the ligands and their individual death receptors leads to activation of caspase-8mediated apoptotic cascade. The intrinsic pathway, also called the mitochondrial apoptosis pathway, is initiated by intracellular stress, such as oxidative stress or DNA damage, which ultimately results in mitochondrial membrane permeabilization, cytochrome C release, and subsequent activation of caspase-9-mediated apoptotic cascade. Caspase-12 is an endoplasmic reticulum (ER) resident caspase that has been recently identified to mediate ER stress-induced apoptosis, such as high calcium concentration or low oxygen . Ischemia and doxorubicin (DOX) can increase ER stress and apoptosis in the heart (Lam et al, 2013; Xu et al, 2015; Fu et al, 2016) . Apoptotic cardiomyocytes are observed in cardiac tissues from patients with MI, dilated cardiomyopathy, and heart failure (Narula et al, 1996; Olivetti et al, 1996; Saraste et al, 1997) , as well as in animal models of different cardiac injuries (Fliss & Gattinger, 1996; Qin et al, 2005) . Pharmacological and genetic inhibition of cardiomyocyte apoptosis diminishes infarct size and improves cardiac function after MI (Whelan et al, 2010) . Therefore, targeting apoptosis is a promising preventive and therapeutic strategy for heart failure (Yang et al, 2013a) .
Prostaglandin (PG) D 2 is a bioactive metabolite of arachidonic acid produced through the sequential reaction of cyclooxygenases (COXs) and PGD 2 synthases. PGD 2 exerts its functions through activation of the D-prostanoid receptor 1 (DP1) and the chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2, also named as DP2). It has been implicated in various pathophysiological events, especially inflammation (Santus & Radovanovic, 2016) . DP1 receptor is abundantly expressed in brain tissues, mast cells, and macrophages, and CRTH2 is highly expressed in immune cell-enriched organs and the heart (Sawyer et al, 2002; Santus & Radovanovic, 2016) . Since DP1 receptor is not detectable in cardiac tissues (Katsumata et al, 2014) , PGD 2 /DP1 axis mediates glucocorticoid-induced cardioprotection against ischemia (Tokudome et al, 2009 ), probably through M2 macrophagemediated timely resolution of inflammation in injured hearts (Kong et al, 2016 (Kong et al, , 2017 . However, the role of CRTH2 in cardiac recovery from ischemia is unknown.
In the present study, we observed that PGD 2 /CRTH2 axis was markedly upregulated in cardiomyocytes in response to anoxia and DOX treatment, which increased ER stress in cardiomyocytes. Unexpectedly, CRTH2 deletion attenuated anoxia or DOX-induced apoptosis in cardiomyocytes and conferred cardioprotection against MI and DOX treatment in mice. CRTH2 deficiency suppressed ERspecific caspase-12 activation in cardiomyocytes by reducing Ca 2+dependent cysteine protease m-calpain activity in mice. In human cardiomyocytes, CRTH2 activation promoted anoxia-induced apoptosis through activating human caspase-4, an ER caspase homolog to mouse caspase-12. Thus, our results demonstrated that CRTH2 facilitated ER stress-induced apoptosis through the m-calpain/ caspase-12 signaling pathway.
Results
PGD 2 /CRTH2 axis is upregulated in cardiomyocytes in response to anoxia
To determine whether PGs are involved in anoxia-induced apoptosis in cardiomyocytes, we isolated primary cardiomyocytes from neonatal mice and examined the alterations of PG production and PG receptor expression in cardiomyocytes in response to anoxia. PGD 2 , PGE 2 , PGF 2a , and TxB 2 were significantly elevated in response to anoxia ( Fig 1A and Appendix Fig S1A) . CRTH2, IP, FP, EP1, and EP4 receptors were abundantly expressed in cardiomyocytes, whereas DP1 was barely detected. Anoxia boosted CRTH2 expression (2.7fold), while repressed FP and EP1 expression ( Fig 1B and Appendix Fig S1B) . To investigate whether the changes in CRTH2, FP, or EP1 receptor contribute to anoxia-induced apoptosis in cardiomyocytes, we directly examined the activation of caspase-3, the main effector caspase, in these receptor agonist-treated cardiomyocytes. The CRTH2 agonist DK-PGD 2 markedly induced caspase-3 activation in cardiomyocytes, but the other agonists (Lat-FA, FP agonist; ONO-DI-004, EP1 agonist; misoprostol, EP4 agonist) had no overt effects on caspase-3 activity ( Fig 1C) . Moreover, CRTH2 expression in cardiomyocytes was gradually increased in response to anoxia in a time-dependent manner ( Fig 1D) . In a murine model of permanent MI, CRTH2 expression increased significantly in the infarct border zone at day 1 post-MI and peaked at day 3, as compared with the remote region ( Fig 1E) . These results indicate that PGD 2 /CRTH2 axis was activated in cardiomyocytes upon anoxic stress.
CRTH2 inhibition protects against MI by reducing ischemia-induced apoptosis in mice
Anoxia resulted in~18.2% apoptosis in cultured cardiomyocytes within 1 h; both TUNEL staining ( Fig EV1A and B) and flow cytometric analysis (Fig EV1C and D) revealed that CRTH2 deletion significantly decreased anoxia-induced apoptosis in cardiomyocytes, with decreased caspase-3 activity in CRTH2 À/À cardiomyocytes ( Fig EV1E) . In agreement with in vitro observations, CRTH2 deficiency reduced apoptotic TUNEL + cardiomyocytes in the infarct border zones after MI in mice (Fig 2A and B) and suppressed caspase-3 activity in ischemic hearts ( Fig 2C) without affecting necrosis and autophagy (Appendix Fig S2A and B) , therefore improving cardiac functions in mice at day 14 after MI ( Fig 2D-F) . Heart dissection showed significant reduction of infarction size in CRTH2 À/À mice compared with WT mice (28.5 AE 2.2% vs. 19.7 AE 1.4%, P < 0.01; Fig 2G and H) . Moreover, CRTH2 À/À mice had lower ratio of heart mass to body weight (HW/BW, Fig 2I) , higher survival rate (87.5% of CRTH2 À/À versus 68.4% of WT; Fig 2J) , and less cardiac collagen deposition at day 14 post-MI than WT mice (Fig 2K and L) . Similarly, CRTH2 blockade with selective antagonist CAY10595 protected hearts from MI as evidenced by increasing heart functions ( Fig EV2A-C) and reducing infarction sizes of hearts ( Fig EV2D-E ). TUNEL immunostaining also confirmed reduced cardiomyocyte apoptosis in the hearts post-MI in CAY10595-treated mice (Fig EV2F-G) . However, no significant differences were found in capillary density (CD31 + ) (Appendix Fig  S3A and B ) and mRNA expression of pro-angiogenic growth factors, such as VEGF, FGF, HGF, and PDGF (Appendix Fig S3C) , in cardiac tissues from the area at risk at day 14 post-MI between WT and CRTH2 À/À mice.
Functional cardiomyocytes can be reprogrammed from fibroblasts by three transcriptional factors-Gata4, Mef2c, and Tbx5 (GMT; Ieda et al, 2010; Wang et al, 2015) . We further investigated the effect of CRTH2 deficiency on reprogramming of cardiac fibroblasts into cardiomyocytes using GMT system. Immunostaining revealed that cardiac troponin T (cTnT)-positive cells (~15%) were induced from cardiac fibroblasts by GMT, but no significant difference of reprogramming efficiency was detected between WT and CRTH2 À/À fibroblasts ( Fig EV3A and B) ; we also observed similar beating rates of cTnT-positive cells transdifferentiated from WT and CRTH2 À/À fibroblasts at different time points tested ( Fig EV3C) . Consistently, similar expression levels of cardiomyocyte-specific genes were induced in WT and CRTH2 À/À fibroblasts by GMT transduction ( Fig EV3D) . These results suggested that CRTH2 is not involved in cardiac reprogramming from fibroblast. CRTH2 +/+ bone marrow (BM) reconstitution does not influence cardiac repair after MI in CRTH2 À/À mice An appropriate inflammatory response is required for cardiac recovery after ischemia (Dutta & Nahrendorf, 2015) . Both macrophages (CD68 + ) and neutrophils (Ly6G + ) were recruited in the infarcted hearts in mice within one week after the test. CRTH2 deficiency showed no overt effects on the recruitment of macrophages and neutrophils (Appendix Fig S4A-D) and expression of related cytokines (Appendix Fig S4E) in the infarcted hearts. CRTH2 mediates Th2 migration and activation in inflammation (Satoh et al, 2006) . CRTH2 deficiency retarded T-cell infiltration (CD4 + ) in periinfarct zones (Appendix Fig S5A and B) and reduced the expression of Th2 cytokines (IL-4, IL-5, and IL-13) in the inflamed hearts after MI (Appendix Fig S5C) . To further explore whether diminished T-cell recruitment conferred cardioprotection against ischemia-induced apoptosis after MI in CRTH2 À/À mice, we reconstituted CRTH2 À/À mice with BM from WT mice ( Fig EV4A) .
Decreased T-cell infiltration in the hearts of CRTH2 À/À mice was restored by WT BM transplantation (WT?KO), whereas that of WT mice that received CRTH2 À/À BM (KO?WT) had significantly lower T cells resident in the infarcted hearts ( Fig EV4B and C) . However, WT BM transplantation did not increase the attenuated cardiomyocyte apoptosis in CRTH2 À/À mice (WT?KO), and CRTH2 À/À BM failed to prevent cardiomyocytes from ischemiainduced apoptosis in WT mice (KO?WT) ( Fig EV4D and E) . Consistently, CRTH2 +/+ BM transplantation had no overt effects on cardiac recovery after MI in CRTH2 À/À mice ( Fig EV4F and G) . Thus, the cardioprotection of CRTH2 deficiency against ischemia in mice may not be mainly ascribed to BM-derived inflammatory cells, including Th2. A The PGD 2 production in neonatal mouse cardiomyocytes challenged by anoxia for 1 h. Data represent mean AE SEM.**P < 0.0001 vs. control (Mann-Whitney U-test); n = 6. B Relative mRNA levels of PGD 2 receptors in mouse cardiomyocytes exposed to anoxia. Data represent mean AE SEM. **P < 0.0001 vs. control (Mann-Whitney U-test); n = 6. C Western blot analysis of caspase-3 in mouse cardiomyocytes treated with PG receptor agonists under anoxia condition. Lat-FA, FP agonist; DK-PGD 2 , CRTH2 agonist;
ONO-DI-004, EP1 agonist; misoprostol, EP4 agonist. D Relative mRNA levels of CRTH2 in mouse cardiomyocytes challenged by anoxia in a time-dependent manner. Data represent mean AE SEM. Anoxia 10 min, *P = 0.029, vs. 0 min (one-way ANOVA); anoxia 30 min, **P = 0.000284 vs. 0 min (one-way ANOVA); anoxia 60 min, **P = 0.00016, vs. 0 min (one-way ANOVA); n = 6. E Relative mRNA levels of CRTH2 in the different regions of mouse heart post-MI. Data represent mean AE SEM. MI day 1, *P = 0.000765, vs. remote area (unpaired two-tailed t-test); MI day 3, *P = 0.0003, vs. remote area (unpaired two-tailed t-test); MI day 7, *P = 0.00542, vs. remote area (unpaired two-tailed t-test); n = 6.
Source data are available online for this figure. A Representative TUNEL-stained images of the peri-infarct area in MI mouse heart. Green, TUNEL-positive nuclei; blue, DAPI; red, a-actinin; scale bar, 50 lm. B
Quantification of TUNEL-positive cardiomyocytes. Data represent mean AE SEM. *P = 0.0147, vs. WT (unpaired two-tailed t-test); WT, n = 6; CRTH2 À/À , n = 8. C
Western blot analysis of the activated caspase-3 in the infarct border zone of mouse heart post-MI. D-F M-mode echocardiographic analysis of cardiac function in mice at day 14 post-MI. EF, ejection fraction (D); FS, fractional shortening (E); LVPWs, left ventricular posterior wall thickness at end-systole. (F). Data represent mean AE SEM. EF, *P = 0.0015, vs. WT (unpaired two-tailed t-test); FS, *P = 0.0015, vs. WT (unpaired two-tailed t-test); LVPWs, *P = 0.00805, vs. WT (unpaired two-tailed t-test); WT, n = 10; CRTH2 À/À , n = 12. G Representative images of Evans blue and TTC-stained mouse heart at day 14 post-MI. Scale bar, 500 lm. H Quantification of infarcted size in mouse heart after MI. Data represent mean AE SEM. **P = 0.00354, vs. WT (unpaired two-tailed t-test); n = 10. I Heart weight-to-body weight ratio in mice subjected to MI. Data represent mean AE SEM. *P = 0.0119, vs. WT (unpaired two-tailed t-test); WT and CRTH2 À/À (Sham), n = 8; WT and CRTH2 À/À (MI), n = 10. J Kaplan-Meier survival curves for mice at day 14 post-MI. *P = 0.0356, vs. WT (log-rank test).WT, n = 29; CRTH2 À/À , n = 26. K Representative images of Masson's trichrome staining of cardiac tissues from infarcted hearts. Scale bar, 20 lm. L Quantification of collagen content in (K). Data represent mean AE SEM. *P = 0.0196, vs. WT (unpaired two-tailed t-test); WT and CRTH2 À/À (Sham), n = 7; WT and CRTH2 À/À (MI), n = 9.
Source data are available online for this figure.
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CRTH2 activation exaggerates anoxia-induced apoptosis in cardiomyocytes through ER caspase-12
Three cardiac apoptotic pathways, such as caspase-8-mediated death receptor pathway, cytochrome C-mediated mitochondrial pathway, and ER caspase-12-initiated pathway, are involved in heart failure van Empel et al, 2005; McIlwain et al, 2013) . We did not detect marked differences in mitochondrial cytochrome C release (Appendix Fig S6A) and the expression of mitochondrial apoptosis-associated genes (Appendix Fig S6B) in cardiac tissues at risk areas in WT and CRTH2 À/À mice. In addition, caspase-8 activity was also not notably changed in infarcted hearts in CRTH2 À/À mice compared with control mice (Appendix Fig S6C) . However, we observed significant reduction of activated caspase-12 and its downstream substrate-cleaved caspase-9 (activated form) in infarcted hearts of CRTH2 À/À mice (Appendix Fig S7A) . This result indicates that ER caspase-12-initiated apoptosis was inhibited in ischemic CRTH2 À/À hearts. Anoxia induced ER stress in cultured cardiomyocytes as evidenced by the increasing phosphorylation of IRE1 and proteolytic cleavage of ATF6 (Appendix Fig S7B) . Moreover, we examined the survival of CRTH2 À/À cardiomyocytes in response to non-ER stress [staurosporine (STS) and TNF-a plus cycloheximide (TNF-a/CHX)] and ER stress-inducing apoptotic stimuli (DOX) (Fu et al, 2016) . CRTH2 À/À cardiomyocytes were more resistant to both anoxia and DOX-induced cell death than WT cardiomyocytes in vitro, but displayed similar sensitivity to non-ER stress-inducing apoptotic stimuli (Appendix Fig S7C) . We investigated the role of caspase-12 in anoxia-induced apoptosis in CRTH2 agonist DK-PGD 2 -treated cardiomyocytes. Caspase-12 knockdown was achieved by adenovirus-guided siRNA approach (Si-Cas.12) (Appendix Fig S7D) . DK-PGD 2 administration increased anoxia-induced apoptosis in myocytes, which were attenuated by Si-Cas.12 adenovirus infection ( Fig 3A and B) . Similarly, Si-Cas.12 infection also blunted the augmented caspase-3 activity in DK-PGD 2treated cardiomyocytes, along with diminished caspase-12 expression ( Fig 3C) . Thus, these results indicate that caspase-12 plays a vital role in CRTH2-mediated cardiomyocyte apoptosis under anoxic stress.
Treatment with DK-PGD 2 impairs cardiac recovery through m-calpain-mediated caspase-12 activation in mice after MI Accumulated evidence suggested that calpain, a family of Ca 2+dependent cytosolic cysteine proteases, is responsible for cleavage and activation of caspase-12 during ER stress-induced apoptosis Sanges et al, 2006; Martinez et al, 2010) . Indeed, significantly lower calpain activity was observed in CRTH2 À/À cardiomyocytes/hearts than in WT cardiomyocytes/ hearts upon anoxia/ischemia (Figs 4A and EV5A) . Moreover, the calpain inhibitor-calpeptin-markedly suppressed augmented apoptosis in CRTH2 agonist DK-PGD 2 -treated cardiomyocytes upon anoxic challenge (Fig 4B and C) and also decreased the cleavage of caspase-12 and caspase-3 as anticipated ( Fig 4D) . Three forms of calpains, namely l-calpain, m-calpain, and calpain-7, were dominantly expressed in cardiomyocytes ( Fig EV5B) and ischemic hearts ( Fig EV5C) . Only m-calpain activity, but not l-calpain and A Calpain activity in mouse cardiomyocytes exposed to anoxia. Data represent mean AE SEM. **P = 0.00518, vs. WT (Mann-Whitney U-test); anoxia 0 min, WT and CRTH2 À/À , n = 4; anoxia 10 min, WT and CRTH2 À/À , n = 6. B Representative TUNEL-stained images of mouse cardiomyocytes treated with calpeptin in the presence of DK-PGD 2 under anoxia condition. Green, TUNEL-positive nuclei; blue, DAPI; red, a-actinin; scale bar, 50 lm. calpain-7, was downregulated in the cardiac tissues of risk areas from CRTH2 À/À mice ( Fig EV5D) . In addition, CRTH2 deficiency had no influence on the expression of endogenous calpain inhibitors (Gas2 or calpastatin; Benetti et al, 2001; Yang et al, 2013b) in mice after MI ( Fig EV5E) . CRTH2 activation by DK-PGD 2 facilitated activation of m-calpain in anoxia-challenged myocytes, without overt effects on l-calpain and calpain-7 ( Fig EV5F and G) . Consistently, silence of either l-calpain or calpain-7 using adenovirus system had no effects on DK-PGD 2 -triggered caspase-12 activation in cardiomyocytes ( Fig EV5F and G) . In contrast, m-calpain silence abolished the increased caspase-12 and caspase-3 activities induced by DK-PGD 2 in cardiomyocytes under anoxia condition ( Fig 4E) . In agreement with observations in the culture, calpeptin significantly abrogated the increased infarct sizes (Fig 5A and B) and improved the impaired left ventricular functions in DK-PGD 2 -treated mice after MI (Fig 5C and D) . Histologically, calpeptin markedly reduced the augmented apoptosis ( Fig 5E and F) and elevated caspase-3 and caspase-12 activities in cardiac tissues at border zones in DK-PGD 2 -treated mice ( Fig 5G) . Hence, CRTH2 activation promoted anoxia-induced apoptosis in myocytes by m-calpain activation.
CRTH2 couples with G aq to activate m-calpain in cardiomyocytes through intracellular Ca 2+ mobilization Calpain activity is mainly dependent on the intracellular calcium (Ca 2+ ) status, and CRTH2 can couple G q/11 proteins (Schrage et al, 2015) to increase intracellular Ca 2+ level (Hirai et al, 2001) . We hypothesized that CRTH2 activation could induce calpain activity through triggering intracellular Ca 2+ release. The mobilization of intracellular Ca 2+ was significantly compromised in CRTH2 À/À cardiomyocytes in response to anoxia ( Fig 6A and B) . Furthermore, U73122, a phospholipase C inhibitor that blocks calcium entry, significantly attenuated the DK-PGD 2 -induced cardiomyocyte apoptosis under anoxia condition (Fig 6C and D) by reducing m-calpain and caspase-12 activities ( Fig 6E) . Co-immunoprecipitation experiments also confirmed that CRTH2 interacted with G q/11 ( Fig 6F) . These results indicate that CRTH2 promotes calpain activity to initiate cardiomyocyte apoptosis under ER stress by triggering G aq -dependent Ca 2+ influx.
CRTH2 deletion reduces DOX-induced cardiomyocyte apoptosis and cardiac injury in mice
Doxorubicin is an effective chemotherapeutic agent that displays severe cardiotoxicity (Singal & Iliskovic, 1998) . As described previously (Fu et al, 2016) , DOX treatment increased ER stress markers in cardiomyocytes including p-IRE1 and cleaved ATF6 ( Fig 7A) . Interestingly, DOX significantly upregulated CRTH2 gene expression in cardiomyocytes in a time-dependent manner ( Fig 7B) . Deletion of CRTH2 markedly ameliorated the left ventricular function and improved the survival rate in mice after DOX treatment (Fig 7C-F) by suppressing DOX-induced cardiomyocyte apoptosis (Fig 7G and H) . Importantly, CRTH2 deficiency also led to the reduction of m-calpain, caspase-12, and caspase-3 activities in cardiac tissues from DOX-treated mice (Fig 7I) . Taken all together, CRTH2 activation promotes ER stress-induced cardiomyocyte apoptosis through the m-calpain/caspase-12 signaling pathway (Fig 7J) .
Caspase-4 silencing reduces anoxia-induced apoptosis in DK-PGD 2 -treated human cardiomyocytes
In most humans, caspase-12 appears to be nonfunctional due to a truncating mutation (Fischer et al, 2002) . Human caspase-4 is the most homologous to mouse caspase-12 and alternatively involved in mediation of ER stress-induced apoptosis in various human cells (Hitomi et al, 2004; Li et al, 2013; Matsunaga et al, 2016; Montagnani Marelli et al, 2016) . To test whether human caspase-4 mediates CRTH2 activation-induced apoptosis in human cardiomyocytes, we used adenovirus system to silence caspase-4 in AC16 human cardiomyocytes ( Fig 8A) . As shown in Fig 8B-D, CRTH2 agonist DK-PGD 2 , indeed, promoted caspase-4 activity in AC16 cells under anoxia condition, along with increased caspase-3 activity. Caspase-4 silence attenuated the increased caspase-3 activity in DK-PGD 2treated AC16 cells, thus suppressing the enhanced apoptosis in AC16 cells treated with DK-PGD 2 .
Discussion
Myocardial ischemia is a common stress condition that results in loss of cardiomyocytes. In this study, we observed that both ischemia and DOX treatment upregulated PGD 2 receptor CRTH2 expression in cardiomyocytes, along with increasing ER stress. Disruption of CRTH2 receptor markedly improved cardiac function after MI and DOX challenge by attenuating apoptosis in cardiomyocytes. In vitro, CRTH2 agonist promoted anoxia-induced apoptosis through activating ER-specific caspase-12. Mechanistically, CRTH2 coupled with G aq activated caspase-12 in cardiomyocytes by Ca 2+dependent m-calpain activation. Calpain inhibition or knockdown of caspase-12 blocked CRTH2-augmented apoptosis in anoxiatreated cardiomyocytes. Therefore, CRTH2 activation facilitates ER stress-induced apoptosis through the m-calpain/caspase-12 pathway.
We and others found that massive PGs are generated in the heart after MI (Kong et al, 2016; Tang et al, 2017) or DOX challenge (Robison & Giri, 1987) . Moreover, cardiac-generated PGs, particularly PGD 2 , mediate cardiac myocyte apoptosis after myocardial ischemia (Qiu et al, 2012) . PGD 2 receptor CRTH2, originally cloned in Th2 cells (Nagata et al, 1999) , is also highly expressed in cardiac tissues (Sawyer et al, 2002) , and its expression is also increased in response to ER stress, such as anoxia and DOX treatment. Genetic ablation of CRTH2 ameliorated cardiac myocyte loss and facilitated cardiac recovery after MI and DOX treatment. A previous study reported that COX-2 inhibitor treatment improves left ventricular function and mortality in a murine model of DOX-induced heart failure (Delgado et al, 2004) . This result suggests that COX-2/PGD 2 / CRTH2 axis is involved in heart injury induced by DOX, perhaps by ischemia. Interestingly, PGD 2 dehydration product, 15-deoxy-D¹² , ¹ 4 -PGJ₂, promotes apoptosis in cultured cardiomyocytes through the CRTH2/MAPK/TNF-a-mediated apoptotic pathway (Koyani et al, 2014) . Paradoxically, investigators also reported that treatment with 15-deoxy-D¹² , ¹ 4 -PGJ₂ decreases TNF-a production in cardiomyocytes and reduces myocardial damage of ischemia/reperfusion (Zingarelli et al, 2007; Liu et al, 2009 ). The discrepancy may be attributed to the activation of PPAR-gamma by 15-deoxy-D¹² , ¹ 4 -PGJ₂ (Harmon et al, 2011) . In agreement with our observations, PGD 2 /CRTH2 axis Calpains, a family of proteases, are involved in a multitude of physiological and pathological conditions through modulating the functions of their substrates (Ono et al, 2016) . l-calpain and m-calpain are the most ubiquitously expressed family members and can be activated in vitro by micromolar and millimolar concentrations of calcium, respectively (Ono et al, 2016) . However, genetic studies have shown mice lacking l-calpain gene grow normally (Azam et al, 2001) , but m-calpain-deficient mice are embryonically lethal (Dutt et al, 2006 ), suggesting mcalpain plays more important physiological functions in vivo than l-calpain. In addition to Ca 2+ binding, phosphorylation of calpain can also increase its activity (Xu & Deng, 2004 (Du et al, 2017) . We observed m-calpain, l-calpain, and calpain-7 were exclusively expressed in cardiomyocytes, and only m-calpain activity was markedly suppressed in CRTH2 À/À cardiomyocytes. Calpain-7 lacks the EF-hand domain and its activity does not depend on Ca 2+ (Osako et al, 2010) . Genetic approaches further confirmed m-calpain is involved in CRTH2-mediated apoptosis in cardiomyocytes. Procaspase-12, which is predominantly located in the ER, can be activated through ER stress (Szegezdi et al, 2003) or cleavage by m-calpain at T132 and K158 . Notably, a significantly lower activity of m-calpain was detected in CRTH2 À/À cardiomyocytes. Inhibition of m-calpain effectively protected cardiomyocytes against CRTH2 agonistinduced apoptosis under ER stress by suppressing caspase-12 activity. Similarly, calpain-mediated caspase-12 activation is also involved in TNF-a-induced apoptosis in cardiomyocytes (Bajaj & Sharma, 2006) , neuron apoptosis in retinitis pigmentosa (Sanges et al, 2006) , and hydroxyeicosatetraenoic acidinduced fibroblast apoptosis (Nieves & Moreno, 2007) . In humans, functional caspase-12 is lost due to a frameshift mutation and a premature stop codon in its transcript (Fischer et al, 2002) . Caspase-4, homolog to mouse caspase-12, can function as ER stress-induced caspase in human cells (Hitomi et al, 2004; Simard et al, 2015; Montagnani Marelli et al, 2016) . Knocking down caspase-4 attenuated anoxia-induced apoptosis in CRTH2 agonist-treated human cardiomyocytes. Calpain activity is mainly dependent on the intracellular Ca 2+ (Potz et al, 2016) . We observed that CRTH2 was coupled with G aq in cardiomyocytes. CRTH2 deficiency markedly reduced intracellular Ca 2+ levels in cardiomyocytes in response to anoxia. Blockage of calcium entry dramatically suppressed m-calpain/ caspase-12 activity and subsequently reduced the exaggerated apoptosis in CRTH2 agonist-treated cardiomyocytes. This result indicates that CRTH2-mediated intracellular Ca 2+ mobilization activates m-calpain/caspase-12 signaling. Accordingly, enhanced G aq signaling has been shown to trigger apoptotic cardiomyopathy and heart failure (Adams et al, 1998; Yussman et al, 2002) . Thus, activation of CRTH2 may facilitate calpaininitiated cardiomyocyte apoptosis under ER stress via the G aq -Ca 2+ pathway.
In summary, stimulation of CRTH2 receptor exerts pro-apoptotic effect in cardiomyocytes via the calpain/caspase-12 signaling pathway. Thus, the inhibition of CRTH2 may have therapeutic potential for apoptotic cardiomyopathy.
Materials and Methods
Animals CRTH2 knockout mice (Satoh et al, 2006) and wild-type littermates (C57BL/6J genetic background) were housed in polypropylene cages and maintained in a temperature-controlled (22 AE 1°C) and relative humidity (50 AE 5%) environment with 12-h dark-light cycle and feed by sterile food and water ad libitum. Essential cleanliness and sterile condition were adopted according to SPF facilities. All animal experiments were performed in accordance with the approval of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences, University of Chinese Academy of Sciences.
Reagents
Calpeptin, arachidonic acid, CAY10595, and 13, 14-dihydro-15-keto PGD 2 were purchased from Cayman Chemical Company (Cayman Chemical, Ann Arbor, MI, USA). U-73122, staurosporine, cycloheximide, and DOX were obtained from Sigma Company (Sigma-Aldrich, St. Louis, MO, USA). TNF-a was purchased from Peprotech (Peprotech Inc., Rocky Hill, NJ, USA).
Mouse MI model
Mice were subjected to a permanent ligation of the left anterior descending artery or to a sham operation as described previously (Gao et al, 2010) . Briefly, 6-to 8-week-old male mice were anesthetized with isoflurane and placed on a heating pad (37°C). Heart was pushed out at the fourth intercostal space after a small hole was made with a mosquito clamp. The left anterior descending coronary artery (LAD) was then located, sutured, and ligated at a sitẽ 3 mm from its origin using a 6-0 silk suture. Sham-operated animals were subjected to the same procedures without ligation. Mice were sacrificed at specified days, and hearts were removed and fixed, or dissected for protein or RNA assay. The infarcted size was determined as previously described (Qian et al, 2011) . The infarct size weight was calculated using the following formula:
A is the percent of infarcted area in the slice, and W is the weight of the respective slices.
Drug administration in mice was performed as previously described (Mani et al, 2009; Maicas et al, 2012; Zhang et al, 2016) . In brief, 6-to 8-week-old male mice were given subcutaneous injections of DK-PGD 2 (0.6 mg/kg) and calpeptin (0.5 mg/ kg), or CAY10595 (5 mg/kg) 15 min before MI induction. Subsequently, mice were treated with DK-PGD 2 (0.3 mg/kg/twice a day) and calpeptin (0.5 mg/kg/day) by subcutaneous injection, or CAY10595 (5 mg/kg/day) by oral gavage until terminal echocardiography procedures were completed. DOX (20 mg/kg) was administered by a single intraperitoneal injection (i.p.), and cardiac function was then assessed by echocardiography 7 days later.
Isolation and culture of neonatal mouse cardiomyocyte
Neonatal mouse cardiomyocytes were isolated and collected according to the instructions of Neonatal Rat/Mouse Cardiomyocyte Isolation Kit (Cellutron Life Technologies, MD, USA). In brief, hearts from postnatal mice (P1) were separated, and ventricular cells were released with digestion buffer at 37°C.
Ventricular cardiomyocytes were grown in NS medium (Cellutron Life Technology) supplemented with 10% fetal bovine serum. For anoxia culture, cardiomyocytes were placed in an anoxic chamber with a water-saturated atmosphere composed of 5% CO 2 and 95% N 2 at 37°C as previously described (Mehrhof et al, 2001) .
PG extraction and analysis
Cultured cardiomyocytes were incubated with arachidonic acid (30 lmol/l), and culture supernatants were used for PG extraction. After centrifugation at 12,000 g for 15 min at 4°C, internal standards (2 ll), 40 ll of citric (1 M), and 5 ll of BHT were added to the sample and then strenuously vibrated with 1 ml of solvent (normal hexane: ethyl acetate, 1:1) for 1 min. After centrifugation at 6,000 g for 10 min, the supernatant organic phase was collected and dried under a gentle stream of nitrogen and dissolved in 100 ll of 10% acetonitrile in water. The prostanoid metabolites were quantitated using liquid chromatography/mass spectrometry/mass spectrometry analyses. The level of PGs was normalized to total protein concentration.
Cell sorting from post-MI hearts
At indicated time point after MI, male mice were anesthetized and perfused intracardially with 30 ml of pre-cooled phosphatebuffered saline (PBS) to exclude blood cells. Subsequently, the border zone and infarcted region of the heart were dissected, minced, and enzymatically digested with a cocktail of collagenase II (450 U/ml), collagenase XI (125 U/ml), DNase I (60 U/ ml), and hyaluronidase (60 U/ml) (Sigma-Aldrich) at 37°C for 1.5 h with gentle shake. The digestion mixture was then passed through a 70-lm cell strainer. Leukocyte-enriched fractions were isolated by density gradient centrifugation on a 40-70% Percoll gradient (GE Healthcare, Uppsala, Sweden). Cells at the 40/70 interface were then collected for inflammatory cytokine gene detection as previously described (Zouggari et al, 2013) .
Evaluation of apoptosis
Apoptotic cells in both tissue sections and cultured cells were assayed by the terminal deoxynucleotidyl transferased UTP nickend labeling (TUNEL) method. TUNEL was performed according to the protocol provided by the manufacturer (Roche Applied Science, Indianapolis IN, USA). Nuclear density was determined by counting DAPI-stained nuclei in 20 different fields for each sample.
Immunofluorescence staining
Frozen sections and cell climbing slices were fixed in cold acetone, washed with PBS, and then incubated with 3% BSA in PBS for 60 min to block nonspecific binding of the antibodies. Thereafter, the samples were incubated with primary antibodies specific to mouse CD68 (diluted 1:200; Serotec), Ly6G (diluted 1:50; BD Biosciences), CD4 (diluted 1:200; eBioscience), CD31 (diluted 1:500; BD Biosciences), cardiac troponin T (diluted 1: 100; Santa Cruz Biotechnology), or a-actinin (diluted 1:1,000; Sigma-Aldrich) overnight at 4°C. Afterward, the slides were washed with PBS three times and incubated with corresponding secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 555 (diluted 1:1000; Invitrogen, Carlsbad, CA, USA) at room temperature for 2 h. Sample was mounted in ProLong Gold antifade reagent with DAPI (Invitrogen). All of the immunofluorescence images were captured and analyzed using a laser-scanning confocal microscope (Carl Zeiss, Oberkochen, Germany) . For the MI model, at least 10 random images from three different sections were obtained from each animal. For cells growing on the glass slide, at least five random fields were taken in the central region of each sample .
Echocardiography
Echocardiography was performed using a Visual Sonics Vevo 770 high-resolution imaging system with a 15-MHz linear-array transducer (Visual Sonics Inc., Toronto, Canada). Male mice were anesthetized with isoflurane, and the heart was imaged in the two-dimensional parasternal short-axis view. An M-mode echocardiogram of the midventricle was then recorded at the level of papillary muscles. Cardiac function was evaluated as previously described (Liao et al, 2002) .
Bone marrow transplantation
Bone marrow transplantation (BMT) was performed as previously described (Shi et al, 2014) . In brief, male mice (6-8 weeks old) were euthanized, and BM cells were collected from the femurs and tibias. Recipient mice were lethally irradiated with a total of 9.5 Gy of total body irradiation administered in three bursts (one 3.5-Gy dose and two 3-Gy doses administered 1.5 h apart) from a 137 Cs source (MDS Nordion, Ottawa, Ontario, Canada) and transplanted with 5 × 10 6 donor BM cells via tail vein injection to reconstitute the hematopoietic system. Eight weeks after transplantation, BMT chimeric mice were used for experiments.
Western blot analysis
Protein from the heart and cardiomyocytes was extracted in the lysis buffer with protease inhibitors. The protein concentrations were determined using Pierce BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Equivalent levels of proteins were denatured and resolved with 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and then transferred to nitrocellulose membranes, incubated with 5% skimmed milk, and probed with primary antibodies overnight at 4°C. Primary antibodies were diluted as follows: anti-cleaved-caspase-3 (1:1,000; Signalway Antibody LLC), anti-mouse GAPDH, anti-HA-tag, anti-m-calpain, anti-l-calpain, anti-caspase-12, anti-IRE1 (1:1,000; Cell Signaling Technology), anti-calpain-7 (1:1,000; ProteinTech Group, Chicago, IL, USA), anti-P-IRE1(1:1,000; Littleton, CO, USA), anti-ATF6 (1:500, Santa Cruz, CA, USA), anti-LC3A/B, anti-phospho-MLKL, anti-MLKL (1:1,000; Cell Signaling Technology), anti-caspase-4, anti-caspase-8, and anticaspase-9 (1:1,000; ABclonal). The membranes were washed and then incubated in horseradish peroxidase-labeled secondary antibody for 1-2 h at room temperature. Proteins were detected using enhanced chemiluminescence reagents (Thermo Scientific, Waltham, MA, USA), and blots were quantified with ImageJ and normalized by GAPDH.
Adenovirus generation and infection
Adenoviruses were constructed using the AdEasy Adenoviral System (Qibogene, Irvine, CA) as previously described (Luo et al, 2007) . In brief, the pAd-Track-CMV-GFP (+) vector containing full-length cDNA that encodes mouse CRTH2 or the pAd-Track-CMV-GFP (À) vector containing specific siRNA hairpin was generated in the HEK293 viral packaging cell line. After several rounds of amplification, recombinant adenovirus was purified by ultracentrifugation in a density cesium chloride gradient. The infection efficiency was estimated by determining the fluorescence of GFP. Adenoviral infection of cardiomyocytes was performed as described previously (Sundaresan Appendix  Table S1 .
RNA extraction and quantitative real-time polymerase chain reaction
Total RNA from the hearts or cardiomyocytes was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Total RNA (1 lg) was reverse-transcribed to cDNA using a Reverse Transcription Reagent kit (Takara, Dalian, China) according to the manufacturer's method. Target gene expression was normalized to the level of gapdh mRNA. The quantitative real-time polymerase chain reaction (qRT-PCR) protocol was as follows: 5 min at 95°C for one cycle, followed by 40 cycles at 95°C for 30 s, 60°C for 30 s, and 72°C for 25 s, and a final extension at 72°C for 10 min. Dissociation curve was obtained for each PCR product. All the primer sequences are listed in Appendix  Table S2 .
CCK-8 assay
Cardiomyocytes were seeded into 96-well plates at the same density and cultured for 8 h. At the end of the culture, the medium was removed and replaced with 100 ll of fresh medium and 10 ll of Cell Counting Kit-8 (CCK-8) assay kit reagent (Dojindo Laboratories, Kumamoto, Japan). Plates were incubated at 37°C for 1 h, and the absorbance was then measured at 450 nm using a Spec-traMax 190 microplate reader (Molecular Devices). Background absorbance value (from wells without cells) was subtracted from all values.
Calpain activity assay
Calpain activity assay was performed using a kit according to the manufacturer's instructions (Calbiochem, San Diego, CA, USA). Fluorescence value was recorded at an excitation wavelength of 360-380 nm and an emission wavelength of 440-460 nm by using a fluorescence plate reader. Relative fluorescence units were then calculated.
Confocal calcium imaging
Calcium imaging was recorded in cardiomyocytes using a laserscanning confocal microscope (Carl Zeiss, Inc., Germany) as previously described . Briefly, cells were treated with 5 lg/ml Fluo-3 (Dojindo Laboratories, Kumamoto, Japan) in Hank's balanced salt solution (HBSS; Invitrogen) at 37°C for 30 min. After washing, cells were incubated in HBSS during calcium imaging. Images were obtained in the line-scan mode with 512 pixels per line at a rate of 5 ms per scan and excited at 488 nm. Two-dimensional images were acquired with the confocal microscope operated at the frame-scan mode (X-Y, 512 × 512 pixels).
Immunoprecipitation
Cardiomyocytes were transfected with adenovirus harboring CRTH2 cDNA or empty vector with HA-tag. The whole-cell lysates were incubated with 5 ll of HA-tag antibody or normal IgG (Cell Signaling Technology) control at 4°C for 3 h and then incubated with protein A/G agarose (Invitrogen) at 4°C overnight with gentle agitation. After washing three times, the immune complexes were recovered by boiling in SDS loading buffer and then subjected to Western blot analysis with HA-tag antibody or anti-G q/11 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Isolation of cardiac fibroblasts
Cardiac fibroblast isolation was performed as described previously (Qian et al, 2013; Lalit et al, 2016) . Briefly, mouse cardiac fibroblasts (CFs) were derived from day 1 to day 3 neonatal pups. Isolated neonatal hearts were minced into small pieces less than 1 mm 3 in size, explants were then plated on 0.1% gelatin-coated dishes in fibroblast medium (IMDM/20% FBS) for 7 days. Then the migrated fibroblasts were trypsinized and filtered through 40-lm cell strainers (Thermo Scientific) to remove tissue fragments. Cardiomyocyte contamination was examined before experiments by staining cardiac troponin T (cTnT).
Production of retroviruses and induction of reprogramming
Cardiac reprogramming of murine cardiac fibroblasts was performed as previously described . Briefly, pMXs-based retroviral vectors (Gata4, Mef2c, Tbx5) were introduced into Plat-E cells using Lipofectamine 2000 transfection reagent (Life Technologies) according to the manufacturer's recommendations. Medium was changed the next day and virus-containing supernatant was collected 48 h after transfection and centrifuged at 48,400 g for 2 h at 4°C. Viruses were then re-suspended by fibroblast media supplemented with 4 lg/ml polybrane (Life Technologies) and added to target cells immediately; 24 h after infection, the culture medium was replaced with cardiomyocyte culture medium (iCM medium, 10% FBS of DMEM/M199 (4:1)) and changed every 3-4 days.
Statistical analysis
All data are expressed as the mean AE standard error of the mean (SEM). Statistical analysis was performed using SPSS version 16.0 software (SPSS Inc., Chicago, IL, USA). Normality of distribution was assessed using the Kolmogorov-Smirnov test. Unpaired Student's t-test, Mann-Whitney U-test, or one-way analysis of variance followed by Bonferroni post hoc test was used to compare two and multiple groups, respectively. Survival rates were compared using the log-rank test. P-values of < 0.05 were considered statistically significant.
Expanded View for this article is available online.
Results
We found that activation of CRTH2 promoted ER stress-induced cardiomyocyte apoptosis in mice postmyocardial infarction and doxorubicin challenge through the G aq /m-calpain/caspase-12 signaling pathway. CRHT2 activation also induced apoptosis in human cardiomyocytes in response to anoxia by increasing caspase-4 activity, an alternative to caspase-12 in humans.
Impact
Our result suggested that CRTH2 inhibition may have therapeutic potential for ischemic cardiomyopathy.
